Home > Products > CD30 & CD64
> Human Anti-CD30 x Anti-CD64 Bispecific Antibody (IgG-IgG)
Human Anti-CD30 x Anti-CD64 Bispecific Antibody (IgG-IgG) (CAT#: BSIG-H284)
Anti-CD30 x Anti-CD64 Bispecific Antibody (IgG-IgG) is designed to be generated by crosslinking two full length IgGs, anti-CD30 and anti-CD64 parental antibodies. A stable linkage is formed between the two antibodies. This BsAb can retarget neutrophilscells to tumor cells. It is designed for the research of Neuroblastoma; Osteosarcoma; Hodgkin lymphoma; T cell lymphoma; Anaplastic large cell lymphoma (ALCL) therapy.
FCGR1A; Fc fragment of IgG receptor Ia; CD64; FCRI; CD64A; IGFR1; Cluster of Differentiation 64; FcγRI; FCGR1B; FCGR1C; immunoglobulin G Fc receptor high affinity I; Fc gamma RI
Our products and services are for research use only, and not for use in diagnostic or therapeutic procedures.
There are currently no customer reviews or questions for Human Anti-CD30 x Anti-CD64 Bispecific Antibody (IgG-IgG) (BSIG-H284). Click the button below to contact us or submit your feedback about this product.